| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10071956 | American Journal of Ophthalmology | 2005 | 6 Pages |
Abstract
VKH disease may result in substantial visual impairment. The use of oral corticosteroid or immunosuppressive drug therapy may reduce the risk of vision loss during the follow-up period.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Irina MD, Jennifer E. MD, John H. MD, PhD, James P. MD, Douglas A. MD, MBA,